VASH2 and central nervous system cancer: In glioma, H19 increases vasohibin 2 (VASH2) levels and Wnt/β-catenin signaling via impairing the action of miR-29a-3p and miR-342, respectively, actuating angiogenesis as a consequence [185,186].